nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—CYP2A6—stomach cancer	0.27	0.535	CbGaD
Eletriptan—HTR1A—stomach cancer	0.235	0.465	CbGaD
Eletriptan—ABCB1—Mitomycin—stomach cancer	0.0555	0.276	CbGbCtD
Eletriptan—CYP2A6—Fluorouracil—stomach cancer	0.0409	0.204	CbGbCtD
Eletriptan—CYP2C9—Capecitabine—stomach cancer	0.0237	0.118	CbGbCtD
Eletriptan—ABCB1—Irinotecan—stomach cancer	0.0142	0.0708	CbGbCtD
Eletriptan—CYP2C9—Fluorouracil—stomach cancer	0.0141	0.07	CbGbCtD
Eletriptan—ABCB1—Docetaxel—stomach cancer	0.0104	0.0519	CbGbCtD
Eletriptan—CYP3A4—Irinotecan—stomach cancer	0.00853	0.0424	CbGbCtD
Eletriptan—ABCB1—Doxorubicin—stomach cancer	0.00778	0.0387	CbGbCtD
Eletriptan—ABCB1—Methotrexate—stomach cancer	0.00753	0.0375	CbGbCtD
Eletriptan—CYP2D6—Doxorubicin—stomach cancer	0.00733	0.0365	CbGbCtD
Eletriptan—HTR7—myenteric nerve plexus—stomach cancer	0.00698	0.171	CbGeAlD
Eletriptan—CYP3A4—Docetaxel—stomach cancer	0.00625	0.0311	CbGbCtD
Eletriptan—CYP3A4—Doxorubicin—stomach cancer	0.00466	0.0232	CbGbCtD
Eletriptan—HTR7—vagus nerve—stomach cancer	0.00465	0.114	CbGeAlD
Eletriptan—HTR7—vein—stomach cancer	0.0045	0.11	CbGeAlD
Eletriptan—HTR1B—blood vessel—stomach cancer	0.00185	0.0453	CbGeAlD
Eletriptan—HTR1D—blood vessel—stomach cancer	0.00179	0.0439	CbGeAlD
Eletriptan—HTR7—blood vessel—stomach cancer	0.00143	0.035	CbGeAlD
Eletriptan—Naratriptan—HTR1A—stomach cancer	0.00101	0.353	CrCbGaD
Eletriptan—PTGS1—blood vessel—stomach cancer	0.000986	0.0242	CbGeAlD
Eletriptan—HTR1A—hematopoietic system—stomach cancer	0.000795	0.0195	CbGeAlD
Eletriptan—HTR2B—smooth muscle tissue—stomach cancer	0.000781	0.0192	CbGeAlD
Eletriptan—Zolmitriptan—HTR1A—stomach cancer	0.000763	0.267	CrCbGaD
Eletriptan—HTR7—hematopoietic system—stomach cancer	0.00076	0.0186	CbGeAlD
Eletriptan—CYP2C19—hematopoietic system—stomach cancer	0.000742	0.0182	CbGeAlD
Eletriptan—HTR7—epithelium—stomach cancer	0.000694	0.017	CbGeAlD
Eletriptan—HTR7—smooth muscle tissue—stomach cancer	0.000669	0.0164	CbGeAlD
Eletriptan—HTR2B—digestive system—stomach cancer	0.000617	0.0151	CbGeAlD
Eletriptan—CYP2A6—liver—stomach cancer	0.000598	0.0146	CbGeAlD
Eletriptan—ABCB1—blood vessel—stomach cancer	0.000583	0.0143	CbGeAlD
Eletriptan—CYP2C9—hematopoietic system—stomach cancer	0.000575	0.0141	CbGeAlD
Eletriptan—HTR1B—endocrine gland—stomach cancer	0.000566	0.0139	CbGeAlD
Eletriptan—Sumatriptan—HTR1A—stomach cancer	0.000556	0.195	CrCbGaD
Eletriptan—HTR7—digestive system—stomach cancer	0.000528	0.013	CbGeAlD
Eletriptan—PTGS1—hematopoietic system—stomach cancer	0.000525	0.0129	CbGeAlD
Eletriptan—CYP2C19—digestive system—stomach cancer	0.000516	0.0126	CbGeAlD
Eletriptan—PTGS1—epithelium—stomach cancer	0.00048	0.0118	CbGeAlD
Eletriptan—PTGS1—smooth muscle tissue—stomach cancer	0.000462	0.0113	CbGeAlD
Eletriptan—HTR1A—endocrine gland—stomach cancer	0.000457	0.0112	CbGeAlD
Eletriptan—CYP3A4—hematopoietic system—stomach cancer	0.000439	0.0108	CbGeAlD
Eletriptan—HTR7—endocrine gland—stomach cancer	0.000436	0.0107	CbGeAlD
Eletriptan—CYP2D6—hematopoietic system—stomach cancer	0.000432	0.0106	CbGeAlD
Eletriptan—CYP2C19—endocrine gland—stomach cancer	0.000426	0.0104	CbGeAlD
Eletriptan—CYP2C9—digestive system—stomach cancer	0.0004	0.0098	CbGeAlD
Eletriptan—HTR7—liver—stomach cancer	0.000394	0.00965	CbGeAlD
Eletriptan—CYP2C19—liver—stomach cancer	0.000384	0.00942	CbGeAlD
Eletriptan—PTGS1—digestive system—stomach cancer	0.000365	0.00895	CbGeAlD
Eletriptan—HTR2B—lymph node—stomach cancer	0.000352	0.00864	CbGeAlD
Eletriptan—CYP2C9—endocrine gland—stomach cancer	0.00033	0.0081	CbGeAlD
Eletriptan—ABCB1—hematopoietic system—stomach cancer	0.00031	0.00761	CbGeAlD
Eletriptan—CYP3A4—digestive system—stomach cancer	0.000305	0.00748	CbGeAlD
Eletriptan—PTGS1—endocrine gland—stomach cancer	0.000302	0.0074	CbGeAlD
Eletriptan—CYP2D6—digestive system—stomach cancer	0.0003	0.00736	CbGeAlD
Eletriptan—Mesoridazine—HTR1A—stomach cancer	0.0003	0.105	CrCbGaD
Eletriptan—CYP2C9—liver—stomach cancer	0.000298	0.0073	CbGeAlD
Eletriptan—ABCB1—epithelium—stomach cancer	0.000284	0.00696	CbGeAlD
Eletriptan—ABCB1—pancreas—stomach cancer	0.000253	0.0062	CbGeAlD
Eletriptan—CYP3A4—endocrine gland—stomach cancer	0.000252	0.00618	CbGeAlD
Eletriptan—CYP2D6—endocrine gland—stomach cancer	0.000248	0.00608	CbGeAlD
Eletriptan—CYP3A4—liver—stomach cancer	0.000227	0.00557	CbGeAlD
Eletriptan—Thioridazine—HTR1A—stomach cancer	0.000226	0.0793	CrCbGaD
Eletriptan—CYP2D6—liver—stomach cancer	0.000224	0.00548	CbGeAlD
Eletriptan—ABCB1—lymphoid tissue—stomach cancer	0.000219	0.00536	CbGeAlD
Eletriptan—ABCB1—digestive system—stomach cancer	0.000216	0.00529	CbGeAlD
Eletriptan—PTGS1—lymph node—stomach cancer	0.000209	0.00511	CbGeAlD
Eletriptan—ABCB1—bone marrow—stomach cancer	0.000199	0.00488	CbGeAlD
Eletriptan—ABCB1—endocrine gland—stomach cancer	0.000178	0.00437	CbGeAlD
Eletriptan—ABCB1—liver—stomach cancer	0.000161	0.00394	CbGeAlD
Eletriptan—ABCB1—lymph node—stomach cancer	0.000123	0.00302	CbGeAlD
Eletriptan—Anorexia—Capecitabine—stomach cancer	9.21e-05	0.000548	CcSEcCtD
Eletriptan—Vomiting—Irinotecan—stomach cancer	9.18e-05	0.000547	CcSEcCtD
Eletriptan—Sinusitis—Doxorubicin—stomach cancer	9.17e-05	0.000546	CcSEcCtD
Eletriptan—Immune system disorder—Methotrexate—stomach cancer	9.15e-05	0.000545	CcSEcCtD
Eletriptan—Dizziness—Fluorouracil—stomach cancer	9.15e-05	0.000544	CcSEcCtD
Eletriptan—Visual impairment—Epirubicin—stomach cancer	9.14e-05	0.000544	CcSEcCtD
Eletriptan—Rash—Irinotecan—stomach cancer	9.11e-05	0.000542	CcSEcCtD
Eletriptan—Dermatitis—Irinotecan—stomach cancer	9.1e-05	0.000542	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Docetaxel—stomach cancer	9.1e-05	0.000541	CcSEcCtD
Eletriptan—Chills—Methotrexate—stomach cancer	9.09e-05	0.000541	CcSEcCtD
Eletriptan—Headache—Irinotecan—stomach cancer	9.05e-05	0.000539	CcSEcCtD
Eletriptan—Hypotension—Capecitabine—stomach cancer	9.03e-05	0.000538	CcSEcCtD
Eletriptan—Insomnia—Docetaxel—stomach cancer	9.03e-05	0.000538	CcSEcCtD
Eletriptan—Paraesthesia—Docetaxel—stomach cancer	8.97e-05	0.000534	CcSEcCtD
Eletriptan—Alopecia—Methotrexate—stomach cancer	8.95e-05	0.000533	CcSEcCtD
Eletriptan—Bradycardia—Doxorubicin—stomach cancer	8.93e-05	0.000531	CcSEcCtD
Eletriptan—Dyspnoea—Docetaxel—stomach cancer	8.9e-05	0.00053	CcSEcCtD
Eletriptan—Somnolence—Docetaxel—stomach cancer	8.88e-05	0.000528	CcSEcCtD
Eletriptan—Tinnitus—Epirubicin—stomach cancer	8.84e-05	0.000526	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Capecitabine—stomach cancer	8.81e-05	0.000524	CcSEcCtD
Eletriptan—Flushing—Epirubicin—stomach cancer	8.8e-05	0.000524	CcSEcCtD
Eletriptan—Vomiting—Fluorouracil—stomach cancer	8.8e-05	0.000524	CcSEcCtD
Eletriptan—Rhinitis—Doxorubicin—stomach cancer	8.79e-05	0.000523	CcSEcCtD
Eletriptan—Dyspepsia—Docetaxel—stomach cancer	8.79e-05	0.000523	CcSEcCtD
Eletriptan—Insomnia—Capecitabine—stomach cancer	8.74e-05	0.00052	CcSEcCtD
Eletriptan—Hypoaesthesia—Doxorubicin—stomach cancer	8.73e-05	0.000519	CcSEcCtD
Eletriptan—Rash—Fluorouracil—stomach cancer	8.72e-05	0.000519	CcSEcCtD
Eletriptan—Dermatitis—Fluorouracil—stomach cancer	8.71e-05	0.000519	CcSEcCtD
Eletriptan—Pharyngitis—Doxorubicin—stomach cancer	8.71e-05	0.000518	CcSEcCtD
Eletriptan—Paraesthesia—Capecitabine—stomach cancer	8.68e-05	0.000517	CcSEcCtD
Eletriptan—Decreased appetite—Docetaxel—stomach cancer	8.68e-05	0.000517	CcSEcCtD
Eletriptan—Headache—Fluorouracil—stomach cancer	8.67e-05	0.000516	CcSEcCtD
Eletriptan—Urinary tract disorder—Doxorubicin—stomach cancer	8.66e-05	0.000516	CcSEcCtD
Eletriptan—Oedema peripheral—Doxorubicin—stomach cancer	8.64e-05	0.000514	CcSEcCtD
Eletriptan—Dysgeusia—Methotrexate—stomach cancer	8.63e-05	0.000514	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Docetaxel—stomach cancer	8.62e-05	0.000513	CcSEcCtD
Eletriptan—Dyspnoea—Capecitabine—stomach cancer	8.62e-05	0.000513	CcSEcCtD
Eletriptan—Fatigue—Docetaxel—stomach cancer	8.61e-05	0.000512	CcSEcCtD
Eletriptan—Urethral disorder—Doxorubicin—stomach cancer	8.6e-05	0.000512	CcSEcCtD
Eletriptan—Nausea—Irinotecan—stomach cancer	8.58e-05	0.000511	CcSEcCtD
Eletriptan—Immune system disorder—Epirubicin—stomach cancer	8.56e-05	0.00051	CcSEcCtD
Eletriptan—Pain—Docetaxel—stomach cancer	8.54e-05	0.000508	CcSEcCtD
Eletriptan—Constipation—Docetaxel—stomach cancer	8.54e-05	0.000508	CcSEcCtD
Eletriptan—Back pain—Methotrexate—stomach cancer	8.53e-05	0.000508	CcSEcCtD
Eletriptan—Dyspepsia—Capecitabine—stomach cancer	8.51e-05	0.000506	CcSEcCtD
Eletriptan—Chills—Epirubicin—stomach cancer	8.51e-05	0.000506	CcSEcCtD
Eletriptan—Arrhythmia—Epirubicin—stomach cancer	8.47e-05	0.000504	CcSEcCtD
Eletriptan—Visual impairment—Doxorubicin—stomach cancer	8.45e-05	0.000503	CcSEcCtD
Eletriptan—Decreased appetite—Capecitabine—stomach cancer	8.4e-05	0.0005	CcSEcCtD
Eletriptan—Alopecia—Epirubicin—stomach cancer	8.38e-05	0.000499	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Capecitabine—stomach cancer	8.35e-05	0.000497	CcSEcCtD
Eletriptan—Fatigue—Capecitabine—stomach cancer	8.33e-05	0.000496	CcSEcCtD
Eletriptan—Pain—Capecitabine—stomach cancer	8.27e-05	0.000492	CcSEcCtD
Eletriptan—Constipation—Capecitabine—stomach cancer	8.27e-05	0.000492	CcSEcCtD
Eletriptan—Feeling abnormal—Docetaxel—stomach cancer	8.23e-05	0.00049	CcSEcCtD
Eletriptan—Nausea—Fluorouracil—stomach cancer	8.22e-05	0.000489	CcSEcCtD
Eletriptan—Ill-defined disorder—Methotrexate—stomach cancer	8.18e-05	0.000487	CcSEcCtD
Eletriptan—Tinnitus—Doxorubicin—stomach cancer	8.18e-05	0.000487	CcSEcCtD
Eletriptan—Gastrointestinal pain—Docetaxel—stomach cancer	8.16e-05	0.000486	CcSEcCtD
Eletriptan—Anaemia—Methotrexate—stomach cancer	8.15e-05	0.000485	CcSEcCtD
Eletriptan—Flushing—Doxorubicin—stomach cancer	8.14e-05	0.000485	CcSEcCtD
Eletriptan—Flatulence—Epirubicin—stomach cancer	8.13e-05	0.000484	CcSEcCtD
Eletriptan—Tension—Epirubicin—stomach cancer	8.1e-05	0.000482	CcSEcCtD
Eletriptan—Dysgeusia—Epirubicin—stomach cancer	8.08e-05	0.000481	CcSEcCtD
Eletriptan—Nervousness—Epirubicin—stomach cancer	8.01e-05	0.000477	CcSEcCtD
Eletriptan—Back pain—Epirubicin—stomach cancer	7.98e-05	0.000475	CcSEcCtD
Eletriptan—Feeling abnormal—Capecitabine—stomach cancer	7.97e-05	0.000474	CcSEcCtD
Eletriptan—Malaise—Methotrexate—stomach cancer	7.95e-05	0.000473	CcSEcCtD
Eletriptan—Muscle spasms—Epirubicin—stomach cancer	7.93e-05	0.000472	CcSEcCtD
Eletriptan—Immune system disorder—Doxorubicin—stomach cancer	7.92e-05	0.000472	CcSEcCtD
Eletriptan—Vertigo—Methotrexate—stomach cancer	7.92e-05	0.000472	CcSEcCtD
Eletriptan—Gastrointestinal pain—Capecitabine—stomach cancer	7.91e-05	0.000471	CcSEcCtD
Eletriptan—Body temperature increased—Docetaxel—stomach cancer	7.89e-05	0.00047	CcSEcCtD
Eletriptan—Abdominal pain—Docetaxel—stomach cancer	7.89e-05	0.00047	CcSEcCtD
Eletriptan—Leukopenia—Methotrexate—stomach cancer	7.89e-05	0.00047	CcSEcCtD
Eletriptan—Chills—Doxorubicin—stomach cancer	7.87e-05	0.000468	CcSEcCtD
Eletriptan—Arrhythmia—Doxorubicin—stomach cancer	7.84e-05	0.000466	CcSEcCtD
Eletriptan—Alopecia—Doxorubicin—stomach cancer	7.75e-05	0.000461	CcSEcCtD
Eletriptan—Cough—Methotrexate—stomach cancer	7.69e-05	0.000458	CcSEcCtD
Eletriptan—Urticaria—Capecitabine—stomach cancer	7.68e-05	0.000457	CcSEcCtD
Eletriptan—Ill-defined disorder—Epirubicin—stomach cancer	7.66e-05	0.000456	CcSEcCtD
Eletriptan—Abdominal pain—Capecitabine—stomach cancer	7.64e-05	0.000455	CcSEcCtD
Eletriptan—Body temperature increased—Capecitabine—stomach cancer	7.64e-05	0.000455	CcSEcCtD
Eletriptan—Convulsion—Methotrexate—stomach cancer	7.64e-05	0.000455	CcSEcCtD
Eletriptan—Anaemia—Epirubicin—stomach cancer	7.63e-05	0.000454	CcSEcCtD
Eletriptan—Agitation—Epirubicin—stomach cancer	7.58e-05	0.000451	CcSEcCtD
Eletriptan—Flatulence—Doxorubicin—stomach cancer	7.52e-05	0.000448	CcSEcCtD
Eletriptan—Myalgia—Methotrexate—stomach cancer	7.51e-05	0.000447	CcSEcCtD
Eletriptan—Arthralgia—Methotrexate—stomach cancer	7.51e-05	0.000447	CcSEcCtD
Eletriptan—Tension—Doxorubicin—stomach cancer	7.49e-05	0.000446	CcSEcCtD
Eletriptan—Dysgeusia—Doxorubicin—stomach cancer	7.48e-05	0.000445	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	7.46e-05	0.000444	CcSEcCtD
Eletriptan—Malaise—Epirubicin—stomach cancer	7.44e-05	0.000443	CcSEcCtD
Eletriptan—Discomfort—Methotrexate—stomach cancer	7.42e-05	0.000441	CcSEcCtD
Eletriptan—Nervousness—Doxorubicin—stomach cancer	7.42e-05	0.000441	CcSEcCtD
Eletriptan—Vertigo—Epirubicin—stomach cancer	7.41e-05	0.000441	CcSEcCtD
Eletriptan—Syncope—Epirubicin—stomach cancer	7.4e-05	0.00044	CcSEcCtD
Eletriptan—Leukopenia—Epirubicin—stomach cancer	7.39e-05	0.00044	CcSEcCtD
Eletriptan—Back pain—Doxorubicin—stomach cancer	7.39e-05	0.00044	CcSEcCtD
Eletriptan—Hypersensitivity—Docetaxel—stomach cancer	7.36e-05	0.000438	CcSEcCtD
Eletriptan—Muscle spasms—Doxorubicin—stomach cancer	7.34e-05	0.000437	CcSEcCtD
Eletriptan—Palpitations—Epirubicin—stomach cancer	7.29e-05	0.000434	CcSEcCtD
Eletriptan—Confusional state—Methotrexate—stomach cancer	7.26e-05	0.000432	CcSEcCtD
Eletriptan—Loss of consciousness—Epirubicin—stomach cancer	7.25e-05	0.000432	CcSEcCtD
Eletriptan—Cough—Epirubicin—stomach cancer	7.2e-05	0.000429	CcSEcCtD
Eletriptan—Asthenia—Docetaxel—stomach cancer	7.16e-05	0.000426	CcSEcCtD
Eletriptan—Convulsion—Epirubicin—stomach cancer	7.15e-05	0.000426	CcSEcCtD
Eletriptan—Hypertension—Epirubicin—stomach cancer	7.12e-05	0.000424	CcSEcCtD
Eletriptan—Hypersensitivity—Capecitabine—stomach cancer	7.12e-05	0.000424	CcSEcCtD
Eletriptan—Ill-defined disorder—Doxorubicin—stomach cancer	7.08e-05	0.000422	CcSEcCtD
Eletriptan—Pruritus—Docetaxel—stomach cancer	7.06e-05	0.00042	CcSEcCtD
Eletriptan—Nervous system disorder—Methotrexate—stomach cancer	7.06e-05	0.00042	CcSEcCtD
Eletriptan—Anaemia—Doxorubicin—stomach cancer	7.06e-05	0.00042	CcSEcCtD
Eletriptan—Myalgia—Epirubicin—stomach cancer	7.03e-05	0.000418	CcSEcCtD
Eletriptan—Arthralgia—Epirubicin—stomach cancer	7.03e-05	0.000418	CcSEcCtD
Eletriptan—Agitation—Doxorubicin—stomach cancer	7.02e-05	0.000418	CcSEcCtD
Eletriptan—Anxiety—Epirubicin—stomach cancer	7e-05	0.000417	CcSEcCtD
Eletriptan—Skin disorder—Methotrexate—stomach cancer	6.99e-05	0.000416	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	6.98e-05	0.000415	CcSEcCtD
Eletriptan—Hyperhidrosis—Methotrexate—stomach cancer	6.96e-05	0.000414	CcSEcCtD
Eletriptan—Discomfort—Epirubicin—stomach cancer	6.94e-05	0.000413	CcSEcCtD
Eletriptan—Asthenia—Capecitabine—stomach cancer	6.94e-05	0.000413	CcSEcCtD
Eletriptan—Malaise—Doxorubicin—stomach cancer	6.89e-05	0.00041	CcSEcCtD
Eletriptan—Dry mouth—Epirubicin—stomach cancer	6.87e-05	0.000409	CcSEcCtD
Eletriptan—Vertigo—Doxorubicin—stomach cancer	6.86e-05	0.000408	CcSEcCtD
Eletriptan—Anorexia—Methotrexate—stomach cancer	6.86e-05	0.000408	CcSEcCtD
Eletriptan—Syncope—Doxorubicin—stomach cancer	6.85e-05	0.000408	CcSEcCtD
Eletriptan—Pruritus—Capecitabine—stomach cancer	6.84e-05	0.000407	CcSEcCtD
Eletriptan—Leukopenia—Doxorubicin—stomach cancer	6.83e-05	0.000407	CcSEcCtD
Eletriptan—Diarrhoea—Docetaxel—stomach cancer	6.83e-05	0.000407	CcSEcCtD
Eletriptan—Confusional state—Epirubicin—stomach cancer	6.79e-05	0.000404	CcSEcCtD
Eletriptan—Palpitations—Doxorubicin—stomach cancer	6.75e-05	0.000402	CcSEcCtD
Eletriptan—Oedema—Epirubicin—stomach cancer	6.73e-05	0.000401	CcSEcCtD
Eletriptan—Hypotension—Methotrexate—stomach cancer	6.72e-05	0.0004	CcSEcCtD
Eletriptan—Loss of consciousness—Doxorubicin—stomach cancer	6.71e-05	0.000399	CcSEcCtD
Eletriptan—Cough—Doxorubicin—stomach cancer	6.66e-05	0.000397	CcSEcCtD
Eletriptan—Shock—Epirubicin—stomach cancer	6.63e-05	0.000394	CcSEcCtD
Eletriptan—Convulsion—Doxorubicin—stomach cancer	6.62e-05	0.000394	CcSEcCtD
Eletriptan—Diarrhoea—Capecitabine—stomach cancer	6.61e-05	0.000394	CcSEcCtD
Eletriptan—Nervous system disorder—Epirubicin—stomach cancer	6.6e-05	0.000393	CcSEcCtD
Eletriptan—Dizziness—Docetaxel—stomach cancer	6.6e-05	0.000393	CcSEcCtD
Eletriptan—Hypertension—Doxorubicin—stomach cancer	6.59e-05	0.000392	CcSEcCtD
Eletriptan—Tachycardia—Epirubicin—stomach cancer	6.57e-05	0.000391	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Methotrexate—stomach cancer	6.56e-05	0.00039	CcSEcCtD
Eletriptan—Skin disorder—Epirubicin—stomach cancer	6.54e-05	0.000389	CcSEcCtD
Eletriptan—Hyperhidrosis—Epirubicin—stomach cancer	6.51e-05	0.000388	CcSEcCtD
Eletriptan—Insomnia—Methotrexate—stomach cancer	6.51e-05	0.000387	CcSEcCtD
Eletriptan—Arthralgia—Doxorubicin—stomach cancer	6.5e-05	0.000387	CcSEcCtD
Eletriptan—Myalgia—Doxorubicin—stomach cancer	6.5e-05	0.000387	CcSEcCtD
Eletriptan—Anxiety—Doxorubicin—stomach cancer	6.48e-05	0.000386	CcSEcCtD
Eletriptan—Paraesthesia—Methotrexate—stomach cancer	6.46e-05	0.000385	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	6.46e-05	0.000384	CcSEcCtD
Eletriptan—Discomfort—Doxorubicin—stomach cancer	6.42e-05	0.000382	CcSEcCtD
Eletriptan—Anorexia—Epirubicin—stomach cancer	6.42e-05	0.000382	CcSEcCtD
Eletriptan—Dyspnoea—Methotrexate—stomach cancer	6.42e-05	0.000382	CcSEcCtD
Eletriptan—Somnolence—Methotrexate—stomach cancer	6.4e-05	0.000381	CcSEcCtD
Eletriptan—Dizziness—Capecitabine—stomach cancer	6.39e-05	0.00038	CcSEcCtD
Eletriptan—Dry mouth—Doxorubicin—stomach cancer	6.36e-05	0.000378	CcSEcCtD
Eletriptan—Vomiting—Docetaxel—stomach cancer	6.35e-05	0.000378	CcSEcCtD
Eletriptan—Dyspepsia—Methotrexate—stomach cancer	6.33e-05	0.000377	CcSEcCtD
Eletriptan—Rash—Docetaxel—stomach cancer	6.3e-05	0.000375	CcSEcCtD
Eletriptan—Hypotension—Epirubicin—stomach cancer	6.29e-05	0.000375	CcSEcCtD
Eletriptan—Dermatitis—Docetaxel—stomach cancer	6.29e-05	0.000374	CcSEcCtD
Eletriptan—Confusional state—Doxorubicin—stomach cancer	6.28e-05	0.000374	CcSEcCtD
Eletriptan—Decreased appetite—Methotrexate—stomach cancer	6.26e-05	0.000372	CcSEcCtD
Eletriptan—Headache—Docetaxel—stomach cancer	6.26e-05	0.000372	CcSEcCtD
Eletriptan—Oedema—Doxorubicin—stomach cancer	6.23e-05	0.000371	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Methotrexate—stomach cancer	6.21e-05	0.00037	CcSEcCtD
Eletriptan—Fatigue—Methotrexate—stomach cancer	6.2e-05	0.000369	CcSEcCtD
Eletriptan—Pain—Methotrexate—stomach cancer	6.15e-05	0.000366	CcSEcCtD
Eletriptan—Vomiting—Capecitabine—stomach cancer	6.15e-05	0.000366	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Epirubicin—stomach cancer	6.14e-05	0.000365	CcSEcCtD
Eletriptan—Shock—Doxorubicin—stomach cancer	6.13e-05	0.000365	CcSEcCtD
Eletriptan—Nervous system disorder—Doxorubicin—stomach cancer	6.11e-05	0.000364	CcSEcCtD
Eletriptan—Rash—Capecitabine—stomach cancer	6.1e-05	0.000363	CcSEcCtD
Eletriptan—Insomnia—Epirubicin—stomach cancer	6.09e-05	0.000363	CcSEcCtD
Eletriptan—Dermatitis—Capecitabine—stomach cancer	6.09e-05	0.000362	CcSEcCtD
Eletriptan—Tachycardia—Doxorubicin—stomach cancer	6.08e-05	0.000362	CcSEcCtD
Eletriptan—Headache—Capecitabine—stomach cancer	6.06e-05	0.00036	CcSEcCtD
Eletriptan—Skin disorder—Doxorubicin—stomach cancer	6.05e-05	0.00036	CcSEcCtD
Eletriptan—Paraesthesia—Epirubicin—stomach cancer	6.05e-05	0.00036	CcSEcCtD
Eletriptan—Hyperhidrosis—Doxorubicin—stomach cancer	6.02e-05	0.000359	CcSEcCtD
Eletriptan—Dyspnoea—Epirubicin—stomach cancer	6e-05	0.000357	CcSEcCtD
Eletriptan—Somnolence—Epirubicin—stomach cancer	5.99e-05	0.000356	CcSEcCtD
Eletriptan—Anorexia—Doxorubicin—stomach cancer	5.94e-05	0.000354	CcSEcCtD
Eletriptan—Nausea—Docetaxel—stomach cancer	5.93e-05	0.000353	CcSEcCtD
Eletriptan—Feeling abnormal—Methotrexate—stomach cancer	5.93e-05	0.000353	CcSEcCtD
Eletriptan—Dyspepsia—Epirubicin—stomach cancer	5.93e-05	0.000353	CcSEcCtD
Eletriptan—Gastrointestinal pain—Methotrexate—stomach cancer	5.88e-05	0.00035	CcSEcCtD
Eletriptan—Decreased appetite—Epirubicin—stomach cancer	5.85e-05	0.000348	CcSEcCtD
Eletriptan—Hypotension—Doxorubicin—stomach cancer	5.82e-05	0.000347	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Epirubicin—stomach cancer	5.81e-05	0.000346	CcSEcCtD
Eletriptan—Fatigue—Epirubicin—stomach cancer	5.81e-05	0.000346	CcSEcCtD
Eletriptan—Constipation—Epirubicin—stomach cancer	5.76e-05	0.000343	CcSEcCtD
Eletriptan—Pain—Epirubicin—stomach cancer	5.76e-05	0.000343	CcSEcCtD
Eletriptan—Nausea—Capecitabine—stomach cancer	5.74e-05	0.000342	CcSEcCtD
Eletriptan—Urticaria—Methotrexate—stomach cancer	5.72e-05	0.00034	CcSEcCtD
Eletriptan—Abdominal pain—Methotrexate—stomach cancer	5.69e-05	0.000339	CcSEcCtD
Eletriptan—Body temperature increased—Methotrexate—stomach cancer	5.69e-05	0.000339	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Doxorubicin—stomach cancer	5.68e-05	0.000338	CcSEcCtD
Eletriptan—Insomnia—Doxorubicin—stomach cancer	5.64e-05	0.000335	CcSEcCtD
Eletriptan—Paraesthesia—Doxorubicin—stomach cancer	5.6e-05	0.000333	CcSEcCtD
Eletriptan—Dyspnoea—Doxorubicin—stomach cancer	5.56e-05	0.000331	CcSEcCtD
Eletriptan—Feeling abnormal—Epirubicin—stomach cancer	5.55e-05	0.00033	CcSEcCtD
Eletriptan—Somnolence—Doxorubicin—stomach cancer	5.54e-05	0.00033	CcSEcCtD
Eletriptan—Gastrointestinal pain—Epirubicin—stomach cancer	5.51e-05	0.000328	CcSEcCtD
Eletriptan—Dyspepsia—Doxorubicin—stomach cancer	5.49e-05	0.000326	CcSEcCtD
Eletriptan—Decreased appetite—Doxorubicin—stomach cancer	5.42e-05	0.000322	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Doxorubicin—stomach cancer	5.38e-05	0.00032	CcSEcCtD
Eletriptan—Fatigue—Doxorubicin—stomach cancer	5.37e-05	0.00032	CcSEcCtD
Eletriptan—Urticaria—Epirubicin—stomach cancer	5.35e-05	0.000318	CcSEcCtD
Eletriptan—Pain—Doxorubicin—stomach cancer	5.33e-05	0.000317	CcSEcCtD
Eletriptan—Constipation—Doxorubicin—stomach cancer	5.33e-05	0.000317	CcSEcCtD
Eletriptan—Body temperature increased—Epirubicin—stomach cancer	5.32e-05	0.000317	CcSEcCtD
Eletriptan—Abdominal pain—Epirubicin—stomach cancer	5.32e-05	0.000317	CcSEcCtD
Eletriptan—Hypersensitivity—Methotrexate—stomach cancer	5.3e-05	0.000316	CcSEcCtD
Eletriptan—Asthenia—Methotrexate—stomach cancer	5.16e-05	0.000307	CcSEcCtD
Eletriptan—Feeling abnormal—Doxorubicin—stomach cancer	5.14e-05	0.000306	CcSEcCtD
Eletriptan—Gastrointestinal pain—Doxorubicin—stomach cancer	5.1e-05	0.000303	CcSEcCtD
Eletriptan—Pruritus—Methotrexate—stomach cancer	5.09e-05	0.000303	CcSEcCtD
Eletriptan—Hypersensitivity—Epirubicin—stomach cancer	4.96e-05	0.000295	CcSEcCtD
Eletriptan—Urticaria—Doxorubicin—stomach cancer	4.95e-05	0.000295	CcSEcCtD
Eletriptan—Abdominal pain—Doxorubicin—stomach cancer	4.93e-05	0.000293	CcSEcCtD
Eletriptan—Body temperature increased—Doxorubicin—stomach cancer	4.93e-05	0.000293	CcSEcCtD
Eletriptan—Diarrhoea—Methotrexate—stomach cancer	4.92e-05	0.000293	CcSEcCtD
Eletriptan—Asthenia—Epirubicin—stomach cancer	4.83e-05	0.000288	CcSEcCtD
Eletriptan—Pruritus—Epirubicin—stomach cancer	4.76e-05	0.000284	CcSEcCtD
Eletriptan—Dizziness—Methotrexate—stomach cancer	4.76e-05	0.000283	CcSEcCtD
Eletriptan—Diarrhoea—Epirubicin—stomach cancer	4.61e-05	0.000274	CcSEcCtD
Eletriptan—Hypersensitivity—Doxorubicin—stomach cancer	4.59e-05	0.000273	CcSEcCtD
Eletriptan—Vomiting—Methotrexate—stomach cancer	4.58e-05	0.000272	CcSEcCtD
Eletriptan—Rash—Methotrexate—stomach cancer	4.54e-05	0.00027	CcSEcCtD
Eletriptan—Dermatitis—Methotrexate—stomach cancer	4.53e-05	0.00027	CcSEcCtD
Eletriptan—Headache—Methotrexate—stomach cancer	4.51e-05	0.000268	CcSEcCtD
Eletriptan—Asthenia—Doxorubicin—stomach cancer	4.47e-05	0.000266	CcSEcCtD
Eletriptan—Dizziness—Epirubicin—stomach cancer	4.45e-05	0.000265	CcSEcCtD
Eletriptan—Pruritus—Doxorubicin—stomach cancer	4.41e-05	0.000262	CcSEcCtD
Eletriptan—Vomiting—Epirubicin—stomach cancer	4.28e-05	0.000255	CcSEcCtD
Eletriptan—Nausea—Methotrexate—stomach cancer	4.27e-05	0.000254	CcSEcCtD
Eletriptan—Diarrhoea—Doxorubicin—stomach cancer	4.26e-05	0.000254	CcSEcCtD
Eletriptan—Rash—Epirubicin—stomach cancer	4.25e-05	0.000253	CcSEcCtD
Eletriptan—Dermatitis—Epirubicin—stomach cancer	4.24e-05	0.000253	CcSEcCtD
Eletriptan—Headache—Epirubicin—stomach cancer	4.22e-05	0.000251	CcSEcCtD
Eletriptan—Dizziness—Doxorubicin—stomach cancer	4.12e-05	0.000245	CcSEcCtD
Eletriptan—Nausea—Epirubicin—stomach cancer	4e-05	0.000238	CcSEcCtD
Eletriptan—Vomiting—Doxorubicin—stomach cancer	3.96e-05	0.000236	CcSEcCtD
Eletriptan—Rash—Doxorubicin—stomach cancer	3.93e-05	0.000234	CcSEcCtD
Eletriptan—Dermatitis—Doxorubicin—stomach cancer	3.93e-05	0.000234	CcSEcCtD
Eletriptan—Headache—Doxorubicin—stomach cancer	3.9e-05	0.000232	CcSEcCtD
Eletriptan—Nausea—Doxorubicin—stomach cancer	3.7e-05	0.00022	CcSEcCtD
Eletriptan—HTR1A—Signaling Pathways—IRS2—stomach cancer	5.94e-06	7.24e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—RHOA—stomach cancer	5.94e-06	7.24e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—SREBF2—stomach cancer	5.93e-06	7.23e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—KRAS—stomach cancer	5.93e-06	7.23e-05	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—MAPK1—stomach cancer	5.92e-06	7.22e-05	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—EGFR—stomach cancer	5.92e-06	7.22e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—RHOA—stomach cancer	5.9e-06	7.19e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—MAPK1—stomach cancer	5.89e-06	7.19e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—EGFR—stomach cancer	5.89e-06	7.19e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—NOS3—stomach cancer	5.88e-06	7.17e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—MAPK3—stomach cancer	5.87e-06	7.16e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—RORA—stomach cancer	5.86e-06	7.15e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PPARG—stomach cancer	5.85e-06	7.13e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—NOS3—stomach cancer	5.84e-06	7.12e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—RHOA—stomach cancer	5.78e-06	7.04e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CAV1—stomach cancer	5.76e-06	7.02e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—APOA1—stomach cancer	5.75e-06	7.01e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—NOS3—stomach cancer	5.72e-06	6.97e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—MYC—stomach cancer	5.71e-06	6.96e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CD44—stomach cancer	5.65e-06	6.88e-05	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—PIK3CA—stomach cancer	5.63e-06	6.87e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—SERPINE1—stomach cancer	5.62e-06	6.86e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—PIK3CA—stomach cancer	5.6e-06	6.83e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CD44—stomach cancer	5.6e-06	6.82e-05	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—KRAS—stomach cancer	5.59e-06	6.82e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—MAPK1—stomach cancer	5.58e-06	6.81e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—EGFR—stomach cancer	5.58e-06	6.81e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—KRAS—stomach cancer	5.57e-06	6.79e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—PIK3CA—stomach cancer	5.56e-06	6.78e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PPARG—stomach cancer	5.53e-06	6.74e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—ERBB2—stomach cancer	5.5e-06	6.7e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ALDOB—stomach cancer	5.49e-06	6.7e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PRKCB—stomach cancer	5.48e-06	6.68e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—ERBB2—stomach cancer	5.46e-06	6.66e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL6ST—stomach cancer	5.46e-06	6.66e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—PIK3CA—stomach cancer	5.44e-06	6.64e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	5.43e-06	6.62e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—RHOA—stomach cancer	5.43e-06	6.62e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—NOS3—stomach cancer	5.37e-06	6.55e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—ERBB2—stomach cancer	5.35e-06	6.52e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—KRAS—stomach cancer	5.27e-06	6.43e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—ALB—stomach cancer	5.26e-06	6.41e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—APC—stomach cancer	5.25e-06	6.4e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PPP2R1A—stomach cancer	5.22e-06	6.36e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CXCL8—stomach cancer	5.21e-06	6.36e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—HRAS—stomach cancer	5.18e-06	6.32e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CXCL8—stomach cancer	5.18e-06	6.31e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—HRAS—stomach cancer	5.14e-06	6.27e-05	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—PIK3CA—stomach cancer	5.14e-06	6.26e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GSTP1—stomach cancer	5.12e-06	6.24e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—PIK3CA—stomach cancer	5.11e-06	6.24e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ALOX5—stomach cancer	5.11e-06	6.23e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PPP2R1A—stomach cancer	5.09e-06	6.21e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CDKN1B—stomach cancer	5.09e-06	6.21e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CXCL8—stomach cancer	5.07e-06	6.18e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CDKN1B—stomach cancer	5.06e-06	6.17e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—HMOX1—stomach cancer	5.05e-06	6.16e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—HRAS—stomach cancer	5.04e-06	6.14e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—NOS3—stomach cancer	5.03e-06	6.13e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—MAPK3—stomach cancer	5.02e-06	6.13e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—DPYD—stomach cancer	5.02e-06	6.12e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—ERBB2—stomach cancer	5.02e-06	6.12e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GSTP1—stomach cancer	5e-06	6.09e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—ALB—stomach cancer	4.97e-06	6.06e-05	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TP53—stomach cancer	4.97e-06	6.06e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—IL6—stomach cancer	4.96e-06	6.04e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CDKN1B—stomach cancer	4.95e-06	6.04e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—HMOX1—stomach cancer	4.93e-06	6.01e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—IL6—stomach cancer	4.92e-06	6e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL6R—stomach cancer	4.87e-06	5.94e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CCND1—stomach cancer	4.86e-06	5.92e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—PIK3CA—stomach cancer	4.85e-06	5.91e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—JUN—stomach cancer	4.85e-06	5.91e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CCND1—stomach cancer	4.82e-06	5.88e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—IL6—stomach cancer	4.82e-06	5.88e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—JUN—stomach cancer	4.81e-06	5.87e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PPP2R1A—stomach cancer	4.8e-06	5.85e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—MAPK1—stomach cancer	4.78e-06	5.83e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—EGFR—stomach cancer	4.78e-06	5.83e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CXCL8—stomach cancer	4.76e-06	5.81e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—TYMS—stomach cancer	4.76e-06	5.8e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PPP2R1A—stomach cancer	4.76e-06	5.8e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—NOS3—stomach cancer	4.76e-06	5.8e-05	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—HRAS—stomach cancer	4.75e-06	5.8e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—HRAS—stomach cancer	4.73e-06	5.77e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CCND1—stomach cancer	4.72e-06	5.76e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MMP9—stomach cancer	4.71e-06	5.75e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—JUN—stomach cancer	4.71e-06	5.75e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GSTP1—stomach cancer	4.71e-06	5.74e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GSTM1—stomach cancer	4.7e-06	5.74e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CDKN1A—stomach cancer	4.7e-06	5.73e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TP53—stomach cancer	4.69e-06	5.72e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MMP9—stomach cancer	4.68e-06	5.71e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GSTP1—stomach cancer	4.67e-06	5.69e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CDKN1A—stomach cancer	4.67e-06	5.69e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CDKN1B—stomach cancer	4.65e-06	5.67e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—TYMS—stomach cancer	4.65e-06	5.66e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—HMOX1—stomach cancer	4.64e-06	5.66e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—HMOX1—stomach cancer	4.6e-06	5.61e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PTGS2—stomach cancer	4.6e-06	5.61e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GSTM1—stomach cancer	4.59e-06	5.6e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MMP9—stomach cancer	4.59e-06	5.59e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MAPK8—stomach cancer	4.59e-06	5.59e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CDKN1A—stomach cancer	4.57e-06	5.57e-05	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—PIK3CA—stomach cancer	4.57e-06	5.57e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SERPINE1—stomach cancer	4.56e-06	5.56e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MAPK8—stomach cancer	4.56e-06	5.55e-05	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IL6—stomach cancer	4.55e-06	5.55e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—IL6—stomach cancer	4.53e-06	5.52e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—KRAS—stomach cancer	4.51e-06	5.51e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—HRAS—stomach cancer	4.48e-06	5.47e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MAPK8—stomach cancer	4.46e-06	5.44e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GSTT1—stomach cancer	4.44e-06	5.42e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CCND1—stomach cancer	4.44e-06	5.41e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—JUN—stomach cancer	4.43e-06	5.4e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ERCC2—stomach cancer	4.42e-06	5.39e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—RHOA—stomach cancer	4.4e-06	5.37e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP2A6—stomach cancer	4.39e-06	5.35e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—TYMS—stomach cancer	4.38e-06	5.34e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—NOS3—stomach cancer	4.35e-06	5.31e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PTGS2—stomach cancer	4.35e-06	5.3e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—TYMS—stomach cancer	4.34e-06	5.29e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GSTM1—stomach cancer	4.33e-06	5.28e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ERCC2—stomach cancer	4.32e-06	5.26e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MMP9—stomach cancer	4.31e-06	5.25e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CDKN1A—stomach cancer	4.29e-06	5.23e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IL6—stomach cancer	4.29e-06	5.23e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GSTM1—stomach cancer	4.29e-06	5.23e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—AKR1C3—stomach cancer	4.27e-06	5.21e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—VEGFA—stomach cancer	4.23e-06	5.16e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—VEGFA—stomach cancer	4.21e-06	5.13e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—STAT3—stomach cancer	4.19e-06	5.11e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MAPK8—stomach cancer	4.19e-06	5.11e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—STAT3—stomach cancer	4.16e-06	5.08e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ENO1—stomach cancer	4.16e-06	5.08e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—MTHFR—stomach cancer	4.16e-06	5.07e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—PIK3CA—stomach cancer	4.15e-06	5.06e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—VEGFA—stomach cancer	4.12e-06	5.02e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—STAT3—stomach cancer	4.08e-06	4.97e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—ERBB2—stomach cancer	4.07e-06	4.97e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ERCC2—stomach cancer	4.07e-06	4.96e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—MTHFR—stomach cancer	4.06e-06	4.95e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ERCC2—stomach cancer	4.03e-06	4.92e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MAPK3—stomach cancer	4e-06	4.88e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MAPK3—stomach cancer	3.98e-06	4.85e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MAPK3—stomach cancer	3.9e-06	4.75e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MYC—stomach cancer	3.9e-06	4.75e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MYC—stomach cancer	3.87e-06	4.72e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—VEGFA—stomach cancer	3.87e-06	4.72e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CXCL8—stomach cancer	3.86e-06	4.71e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—HRAS—stomach cancer	3.84e-06	4.68e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CAV1—stomach cancer	3.84e-06	4.68e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—STAT3—stomach cancer	3.83e-06	4.67e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—APOA1—stomach cancer	3.83e-06	4.67e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—MTHFR—stomach cancer	3.82e-06	4.66e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MAPK1—stomach cancer	3.81e-06	4.65e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—EGFR—stomach cancer	3.81e-06	4.65e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—MTHFR—stomach cancer	3.79e-06	4.62e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MYC—stomach cancer	3.79e-06	4.62e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MAPK1—stomach cancer	3.79e-06	4.62e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—EGFR—stomach cancer	3.78e-06	4.62e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CDKN1B—stomach cancer	3.77e-06	4.6e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CAV1—stomach cancer	3.74e-06	4.56e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—APOA1—stomach cancer	3.73e-06	4.55e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MAPK1—stomach cancer	3.71e-06	4.52e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—EGFR—stomach cancer	3.71e-06	4.52e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CD44—stomach cancer	3.69e-06	4.5e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—IL6—stomach cancer	3.67e-06	4.48e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.66e-06	4.47e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MAPK3—stomach cancer	3.66e-06	4.46e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—KRAS—stomach cancer	3.6e-06	4.39e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CCND1—stomach cancer	3.6e-06	4.39e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—JUN—stomach cancer	3.59e-06	4.38e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—KRAS—stomach cancer	3.58e-06	4.36e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MYC—stomach cancer	3.56e-06	4.34e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CAV1—stomach cancer	3.53e-06	4.3e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—APOA1—stomach cancer	3.52e-06	4.29e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—KRAS—stomach cancer	3.5e-06	4.27e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CAV1—stomach cancer	3.5e-06	4.26e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MMP9—stomach cancer	3.49e-06	4.26e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—APOA1—stomach cancer	3.49e-06	4.25e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MAPK1—stomach cancer	3.48e-06	4.25e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—EGFR—stomach cancer	3.48e-06	4.25e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CDKN1A—stomach cancer	3.48e-06	4.25e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MAPK8—stomach cancer	3.4e-06	4.14e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PPARG—stomach cancer	3.37e-06	4.11e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.34e-06	4.07e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PIK3CA—stomach cancer	3.31e-06	4.03e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PPARG—stomach cancer	3.29e-06	4.01e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—KRAS—stomach cancer	3.29e-06	4.01e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PIK3CA—stomach cancer	3.28e-06	4.01e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PIK3CA—stomach cancer	3.22e-06	3.92e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TP53—stomach cancer	3.2e-06	3.9e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TP53—stomach cancer	3.18e-06	3.88e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PPP2R1A—stomach cancer	3.14e-06	3.83e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—VEGFA—stomach cancer	3.14e-06	3.83e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TP53—stomach cancer	3.11e-06	3.79e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—STAT3—stomach cancer	3.11e-06	3.79e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PPARG—stomach cancer	3.1e-06	3.78e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GSTP1—stomach cancer	3.08e-06	3.75e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PPARG—stomach cancer	3.07e-06	3.75e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—HRAS—stomach cancer	3.06e-06	3.73e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—HRAS—stomach cancer	3.04e-06	3.71e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—HMOX1—stomach cancer	3.04e-06	3.7e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ALB—stomach cancer	3.03e-06	3.7e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PIK3CA—stomach cancer	3.02e-06	3.68e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—HRAS—stomach cancer	2.98e-06	3.63e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MAPK3—stomach cancer	2.97e-06	3.62e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ALB—stomach cancer	2.96e-06	3.61e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IL6—stomach cancer	2.93e-06	3.57e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TP53—stomach cancer	2.92e-06	3.56e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IL6—stomach cancer	2.91e-06	3.55e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—NOS3—stomach cancer	2.9e-06	3.54e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MYC—stomach cancer	2.89e-06	3.52e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—TYMS—stomach cancer	2.86e-06	3.49e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IL6—stomach cancer	2.85e-06	3.47e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—NOS3—stomach cancer	2.83e-06	3.45e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PIK3CA—stomach cancer	2.83e-06	3.45e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GSTM1—stomach cancer	2.83e-06	3.45e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MAPK1—stomach cancer	2.82e-06	3.44e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—EGFR—stomach cancer	2.82e-06	3.44e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—HRAS—stomach cancer	2.8e-06	3.41e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ALB—stomach cancer	2.79e-06	3.4e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ALB—stomach cancer	2.76e-06	3.37e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PIK3CA—stomach cancer	2.68e-06	3.26e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IL6—stomach cancer	2.68e-06	3.26e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—NOS3—stomach cancer	2.67e-06	3.25e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—KRAS—stomach cancer	2.67e-06	3.25e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ERCC2—stomach cancer	2.66e-06	3.24e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PTGS2—stomach cancer	2.65e-06	3.23e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—NOS3—stomach cancer	2.64e-06	3.22e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PTGS2—stomach cancer	2.59e-06	3.16e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—MTHFR—stomach cancer	2.5e-06	3.05e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PIK3CA—stomach cancer	2.45e-06	2.99e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PTGS2—stomach cancer	2.44e-06	2.97e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PTGS2—stomach cancer	2.42e-06	2.95e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TP53—stomach cancer	2.37e-06	2.89e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CAV1—stomach cancer	2.31e-06	2.81e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—APOA1—stomach cancer	2.3e-06	2.81e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—HRAS—stomach cancer	2.27e-06	2.76e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL6—stomach cancer	2.17e-06	2.65e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PPARG—stomach cancer	2.03e-06	2.47e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ALB—stomach cancer	1.82e-06	2.22e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—NOS3—stomach cancer	1.74e-06	2.13e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PIK3CA—stomach cancer	1.63e-06	1.99e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PTGS2—stomach cancer	1.59e-06	1.94e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PIK3CA—stomach cancer	1.59e-06	1.94e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.5e-06	1.83e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PIK3CA—stomach cancer	1.49e-06	1.81e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PIK3CA—stomach cancer	9.81e-07	1.2e-05	CbGpPWpGaD
